The Role of Dopamine Agonists in the Treatment of Depression in Patients with Parkinson's Disease: A Systematic Review

Author： Leentjens Albert F.G.  

Publisher： Adis International

ISSN： 0012-6667

Source： Drugs, Vol.71, Iss.3, 2011-02, pp. : 273-286

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The safety of dopamine agonists in the treatment of Parkinson's disease

By Bonuccelli Ubaldo   Ceravolo Roberto  

Expert Opinion on Drug Safety, Vol. 7, Iss. 2, 2008-03 ,pp. : 111-127

Informa Healthcare

Access to resources Recommend Favorite

Dopamine Agonists in Parkinson’s Disease: What is Their Role in Early Treatment?

By Stocchi F.  

CNS Drugs, Vol. 10, Iss. 3, 1998-09 ,pp. : 159-170

Adis International

Access to resources Recommend Favorite

Clinical Review and Treatment of Select Adverse Effects of Dopamine Receptor Agonists in Parkinson's Disease

By Wood Lindy D.  

Drugs & Aging, Vol. 27, Iss. 4, 2010-04 ,pp. : 295-310

Adis International

Access to resources Recommend Favorite

Dopamine agonists in Parkinson’s disease

By Tintner Ron   Jankovic Joseph  

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 11, 2003-11 ,pp. : 1803-1820

Informa Healthcare

Access to resources Recommend Favorite

Cost-Effectiveness Analysis of Dopamine Agonists in the Treatment of Parkinson's Disease in Japan

By Shimbo T.  

PharmacoEconomics, Vol. 19, Iss. 8, 2001-01 ,pp. : 875-886

Adis International

Access to resources Recommend Favorite